The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[28-09-am]Pharmacotherapy (Oncology)

Fri. Mar 28, 2025 8:30 AM - 9:42 AM JST
Fri. Mar 28, 2025 11:30 PM - 12:42 AM UTC
Room 9 (Fukuoka International Congress Center: 411 [4F])
Chair: Takeshi Hirota, Noritaka Ariyoshi
8:30 AM - 8:42 AM JST(11:30 PM - 11:42 PM UTC)

[28-09-am01]Serum, Skin, and Nail Levels of Sunitinib and Metabolites: Their Role in Hand-Foot Skin Reaction Expression

○Miki Takenaka Sato1, Takuya Araki2, Hideaki Yashima2, Jun Morita3,5, Yoshiko Maeda4,5, Masayuki Ohbayashi1, Noriko Kohyama1, Yoshio Ogawa5, Takashi Fukagai5, Koujirou Yamamoto2, Mari Kogo1 (1. Showa Univ. Grad. Sch. Pharm., 2. Grad. Sch. Medicine., Gunma Univ., 3. Urology, Showa University Fujigaoka Hospital, 4. Pelvic Reconstructive Surgery, Tokyo Women's Medical University, Adachi Medical Center, 5. Urology, Showa University Hospital)
8:42 AM - 8:54 AM JST(11:42 PM - 11:54 PM UTC)

[28-09-am02S]KRAS inhibitor tolerant pancreatic cancer cells utilize glutamine metabolism for survival

○Hiroki Furukawa1, Taichi Oshima1, Kosei Ito1, Shigeki Aoki1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
8:54 AM - 9:06 AM JST(11:54 PM - 12:06 AM UTC)

[28-09-am03S]Elucidation the mechanism of clone-specific anaphylaxis induced by anti PD-L1 antibodies

○Ruiheng Tang1, Riho Kume1, Kazuto Yasuda1, Yuta Tamemoto1, Kyohei Higashi2, Hiroto Hatakeyama1 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Pharm. Sci., Tokyo University of Science)
9:06 AM - 9:18 AM JST(12:06 AM - 12:18 AM UTC)

[28-09-am04]Treatment outcome of low-dose chemotherapy combined with hyperthermia for pancreatic cancer with distant metastasis

○Seiji Yamamoto1, Tatsuyoshi Yamamoto2, Kosuke Kawai1, Tsuyoshi Hata1, Shunichiro Komatsu2 (1. Dept. Pharm., Tokai Hosp., 2. Dept. Surg., Tokai Hosp.)
9:18 AM - 9:30 AM JST(12:18 AM - 12:30 AM UTC)

[28-09-am05]Analysis on the Impact of Proton Pump Inhibitor Co-Administration on Immune-Related Adverse Event Incidence Using FAERS

○Junya Hashizume1, Hirotaka Miyamoto2, Shion Harada2, Daichi Kikunaga2, Yukinobu Kodama1, Hirofumi Hamano3, Yoshito Zamami3, kaname Ohyama1 (1. Dept. Hosp. Pharm., Nagasaki Univ, 2. Grad. Sch. Bio. Sci., Nagasaki Univ., 3. Dept. Hosp. Pharm., Okayama Univ.)
9:30 AM - 9:42 AM JST(12:30 AM - 12:42 AM UTC)

[28-09-am06]Development of a strategy to control double-negative prostate cancer using Chb-modified PI-Polyamide

○FENG CAO1, Tatsuya Masuda1, Takayoshi Watanabe1, Toshinori Ozaki1, Yasuhiko Kamikubo1 (1. Chiba Cancer Center Research Institute)
Back to Category List